Home > Insider Trading > Filing (0001209191-14-027984)

Filing Details

Accession Number:: 0001209191-14-027984
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-04-16 19:15:12
Reporting Period:: 2014-04-15

Filing Date:: 2014-04-16
Accepted Time:: 2014-04-16 19:15:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1328143	Adamas Pharmaceuticals Inc	ADMS	Pharmaceutical Preparations (2834)	421560076

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1027621	D Jonathan Feiber	3000 Sand Hill Road Suite 3-290 Menlo Park CA 94025	No	No	Yes	No
1129541	Mdv Vii Lp	3000 Sand Hill Road Suite 3-290 Menlo Park CA 94025	No	No	Yes	No
1250354	J Nancy Schoendorf	3000 Sand Hill Road Suite 3-290 Menlo Park CA 94025	No	No	Yes	No
1410787	Mdv Ix Lp	3000 Sand Hill Road Suite 3-290 Menlo Park CA 94025	No	No	Yes	No
1564546	Seventh Mdv Partners, L.l.c.	3000 Sand Hill Road Suite 3-290 Menlo Park CA 94025	No	No	Yes	No
1573991	Ninth Mdv Partners, L.l.c.	3000 Sand Hill Road Suite 3-290 Menlo Park CA 94025	No	No	Yes	No
1605837	Mdv Enf Vii (A), L.p.	3000 Sand Hill Road Suite 3-290 Menlo Park CA 94025	No	No	Yes	No
1605838	Mdv Enf Vii (B), L.p.	3000 Sand Hill Road Suite 3-290 Menlo Park CA 94025	No	No	Yes	No
1605840	Mdv Vii Leaders' Fund, L.p.	3000 Sand Hill Road Suite 3-290 Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-04-15	1,029,984	$0.00	3,772,686	No	4	C	Indirect	MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP
Common Stock	Acquisiton	2014-04-15	511,328	$0.00	511,328	No	4	C	Indirect	MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF
Common Stock	Acquisiton	2014-04-15	265,150	$16.00	265,150	No	4	P	Indirect	MDV VII, L.P.
Common Stock	Acquisiton	2014-04-15	6,043	$16.00	6,043	No	4	P	Indirect	MDV ENF VII (A), L.P.
Common Stock	Acquisiton	2014-04-15	3,146	$16.00	3,146	No	4	P	Indirect	MDV ENF VII (B), L.P.
Common Stock	Acquisiton	2014-04-15	25,661	$16.00	25,661	No	4	P	Indirect	MDV VII Leaders' Fund, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP
No	4	C	Indirect	MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF
No	4	P	Indirect	MDV VII, L.P.
No	4	P	Indirect	MDV ENF VII (A), L.P.
No	4	P	Indirect	MDV ENF VII (B), L.P.
No	4	P	Indirect	MDV VII Leaders' Fund, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series AA Convertible Preferred Stock	Disposition	2014-04-15	1,029,516	$0.00	1,029,516	$0.00
Common Stock	Series AA Convertible Preferred Stock	Disposition	2014-04-15	468	$0.00	468	$0.00
Common Stock	Series AA-1 Convertible Preferred Stock	Disposition	2014-04-15	511,328	$0.00	511,328	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Upon the closing of the Issuer's initial public offering, each share of Series AA Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date.
Upon the closing of the Issuer's initial public offering, each 1000 shares of Series AA-1 Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date.
Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV VII Leaders' Fund, L.P., MDV ENF VII(A), L.P, and MDV ENF(B), L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII (A), L.P., (iv) MDV ENF VII (B), L.P. and (v) MDV VII Leaders' Fund, L.P. (the "MDV VII Funds") and has sole voting and investment power over the shares. Jonathan Feiber ("Feiber") and Nancy Schoendorf ("Schoendorf") are managing members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and investment power over the shares. Each Reporting Person disclaims beneficial ownership of the shares held by the MDV VII Funds except to the extent of any pecuniary interest therein. William Ericson ("Ericson"), a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with the MDV VII Funds. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports.
Ninth MDV Partners, L.L.C. is the general partner of MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P. Ericson and Feiber are Managing Members of Ninth MDV Partners, L.L.C. Feiber and Ericson may be deemed to share voting and dispositive power over the shares held by MDV IX, as nominee for MDV IX, L.P., and MDV ENF IX, L.P. Each Reporting Person disclaims beneficial ownership of the shares held by MDV IX except to the extent of any pecuniary interest therein. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports.
The shares do not have an expiration date.